Stocks
Intercept Pharmaceuticals (ICPT) Revenue US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| Revenue, bln rub | ? | 179.8 | 252.0 | 312.7 | 363.5 | 285.7 | 317.7 | ||
| Changes by years, y/y, % | +37% | +40% | +24% | +16% | -21% | +16.9% | |||
Intercept Pharmaceuticals. Revenue US GAAP, bln rub
Intercept Pharmaceuticals. Revenue US GAAP, changes, %
Intercept Pharmaceuticals. Revenue US GAAP, sum by quarters, bln rub
Intercept Pharmaceuticals (ICPT) Revenue US GAAP (quarter values) |
||||||||
| 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | LTM ? | |||
| Revenue, bln rub | ? | 77.6 | 77.2 | 68.0 | 83.7 | 88.8 | 317.7 | |
| Changes by years, y/y, % | -16% | -16% | -23% | +17% | +14% | |||
| Changes by quarters, q/q, % | +8% | 0% | -12% | +23% | +6% | |||
